We are live on ! Find out more
PFBT

Parkside Financial Bank & Trust Portfolio holdings

AUM $1.31B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+19.14%
3 Year Est. Return
+63.35%
5 Year Est. Return
+76.33%
10 Year Est. Return
+246.44%
AUM
$148M
AUM Growth
+$19.5M
Cap. Flow
+$8.17M
Cap. Flow %
5.54%
Top 10 Hldgs %
34.84%
Holding
164
New
23
Increased
68
Reduced
47
Closed
9

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$883K
2
KO icon
Coca-Cola
KO
+$701K
3
IWN icon
iShares Russell 2000 Value ETF
IWN
+$655K
4
GSK icon
GSK
GSK
+$593K
5
HD icon
Home Depot
HD
+$572K

Sector Composition

Rank Sector Weight
1 Financials 12.35%
2 Consumer Staples 10.88%
3 Healthcare 9.4%
4 Energy 9.35%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
101
UnitedHealth
UNH
$370B
$323K 0.22%
+4,295
New +$309K
XEC
102
DELISTED
CIMAREX ENERGY CO
XEC
$315K 0.21%
3,000
FDX icon
103
FedEx
FDX
$75.4B
$309K 0.21%
2,155
+200
+10% +$26.5K
TRV icon
104
Travelers Companies
TRV
$80.2B
$306K 0.21%
3,379
+949
+39% +$82.9K
FAST icon
105
Fastenal
FAST
$59.5B
$305K 0.21%
+25,692
New +$309K
IJK icon
106
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
$305K 0.21%
8,124
+1,136
+16% +$41K
DEO icon
107
Diageo
DEO
$53.6B
$299K 0.2%
2,253
TXN icon
108
Texas Instruments
TXN
$261B
$299K 0.2%
6,816
-569
-8% -$23.8K
ALL icon
109
Allstate
ALL
$67.5B
$298K 0.2%
5,442
+45
+0.8% +$2.4K
CB
110
DELISTED
CHUBB CORPORATION
CB
$297K 0.2%
3,067
AZN icon
111
AstraZeneca
AZN
$250B
$294K 0.2%
4,965
+30
+0.6% +$1.63K
NVS icon
112
Novartis
NVS
$297B
$282K 0.19%
3,929
+386
+11% +$26.8K
APD icon
113
Air Products & Chemicals
APD
$67.6B
$279K 0.19%
2,696
+432
+19% +$43.5K
IWV icon
114
iShares Russell 3000 ETF
IWV
$20.4B
$272K 0.18%
2,461
-362
-13% -$38.4K
AEE icon
115
Ameren
AEE
$30.1B
$268K 0.18%
7,412
+128
+2% +$4.59K
SO icon
116
Southern Company
SO
$107B
$268K 0.18%
+6,533
New +$270K
BLK icon
117
Blackrock
BLK
$176B
$257K 0.17%
815
-88
-10% -$26.3K
EL icon
118
Estee Lauder
EL
$32B
$256K 0.17%
3,399
+300
+10% +$21.7K
LVS icon
119
Las Vegas Sands
LVS
$29.6B
$247K 0.17%
3,124
NKE icon
120
Nike
NKE
$61.9B
$244K 0.17%
6,202
+264
+4% +$10.1K
MET icon
121
MetLife
MET
$62.1B
$242K 0.16%
5,046
+80
+2% +$3.59K
FWONA icon
122
Liberty Media Series A
FWONA
$23.6B
$234K 0.16%
+8,995
New +$239K
GILD icon
123
Gilead Sciences
GILD
$165B
$233K 0.16%
+3,097
New +$216K
RDS.B
124
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$232K 0.16%
3,080
+30
+1% +$2.11K
SSO icon
125
ProShares Ultra S&P500
SSO
$8.41B
$229K 0.16%
+35,664
New +$209K

Similar funds

Parkside Financial Bank & Trust's Q4 2013 Portfolio in Review

As of Q4 2013, Parkside Financial Bank & Trust held 164 positions worth $148M, up 15% from $128M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parkside Financial Bank & Trust deployed $8.17M of net new capital in Q4 2013, opening 23 new positions and adding to 68 existing holdings. Its largest new stake was GSK: 9,149 shares worth $611K.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 14% a quarter earlier, followed by Consumer Staples and Healthcare.

On the sell side, the largest reduction was Enterprise Financial Services Corp, an estimated $1.46M trimmed.

  • Parkside Financial Bank & Trust's largest Q4 2013 buy was GSK: 9,149 shares worth $611K.
  • Parkside Financial Bank & Trust added most to ExxonMobil in Q4 2013, an estimated $883K increase.
  • Parkside Financial Bank & Trust's biggest Q4 2013 reduction was Enterprise Financial Services Corp, cutting an estimated $1.46M.
  • Parkside Financial Bank & Trust fully exited Schwab US REIT ETF in Q4 2013, selling an estimated $429K.
  • Parkside Financial Bank & Trust's ten largest holdings make up 35% of its $148M portfolio in Q4 2013.
  • Parkside Financial Bank & Trust opened 23 new positions and closed 9 in Q4 2013.
  • Parkside Financial Bank & Trust's portfolio value rose 15% quarter-over-quarter to $148M.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2013, filed 31 Jan 2014.